Inhibition of autophagy as a therapeutic concept in renal cell carcinoma

被引:0
|
作者
Stuehler, V. [1 ]
Rausch, S. [1 ]
Winter, S. [2 ]
Schmees, C. [3 ]
Stenzl, A. [1 ]
Bedke, J. [1 ]
Schwab, M. [2 ]
Schaeffeler, E. [2 ]
机构
[1] Eberhard Karls Univ Tuebingen, Univ Hosp Tuebingen, Dept Urol, Tubingen, Germany
[2] Univ Tubingen, Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[3] Univ Tubingen, NMI Nat & Med Sci Inst, Reutlingen, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
P0560
引用
下载
收藏
页码:S760 / S760
页数:1
相关论文
共 50 条
  • [21] THERAPEUTIC OPTIONS IN RENAL-CELL CARCINOMA
    BUZAID, AC
    TODD, MB
    SEMINARS IN ONCOLOGY, 1989, 16 (01) : 12 - 19
  • [22] Renal cell carcinoma - Diagnostic and therapeutic - Update
    Jacqmin, D
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2004, 188 (01): : 27 - 35
  • [23] THERAPEUTIC OPTIONS IN RENAL-CELL CARCINOMA
    KROWN, SE
    SEMINARS IN ONCOLOGY, 1985, 12 (04) : 13 - 17
  • [24] AMPK as a therapeutic target in renal cell carcinoma
    Woodard, Jennifer
    Joshi, Sonali
    Viollet, Benoit
    Hay, Nissim
    Platanias, Leonidas C.
    CANCER BIOLOGY & THERAPY, 2010, 10 (11) : 1169 - 1178
  • [25] KCMF1 regulates autophagy and ion channels' function in renal cell carcinoma: a future therapeutic target
    Singh, Ashu
    Choudhury, Saumitra Dey
    Singh, Prabhjot
    Singh, Vishwendra Vikram
    Singh, Som Nath
    Sharma, Alpana
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 5617 - 5626
  • [26] KCMF1 regulates autophagy and ion channels’ function in renal cell carcinoma: a future therapeutic target
    Ashu Singh
    Saumitra Dey Choudhury
    Prabhjot Singh
    Vishwendra Vikram Singh
    Som Nath Singh
    Alpana Sharma
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5617 - 5626
  • [27] Glutaminase inhibition in renal cell carcinoma therapy
    Raczka, Aleksandra M.
    Reynolds, Paul A.
    CANCER DRUG RESISTANCE, 2019, 2 (02) : 356 - 364
  • [28] Exploring the Therapeutic Potential of β-Hydroxybutyrate (BHB) in Clear Cell Renal Cell Carcinoma: A Journey into Fat Browning, Autophagy, and Tumor Slimming
    Rezaei, Roya
    Abdali Larki, Asra
    Hosseinzadegan, Rosa
    Dashti, Zahra
    Tarkashvand, Saba
    Akhoondi, Reihaneh
    Siri, Morvarid
    Shams, Mesbah
    Monsef, Alireza
    Dastghaib, Sanaz
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2024, 2024
  • [29] Multitarget pharmacological inhibition for renal cell carcinoma
    Granovetter, Michael
    LANCET ONCOLOGY, 2016, 17 (04): : E140 - E140
  • [30] mTOR pathway inhibition in renal cell carcinoma
    Pinto Marin, Alvaro
    Redondo Sanchez, Andres
    Espinosa Arranz, Enrique
    Zamora Aunon, Pilar
    Castelo Fernandez, Beatriz
    Gonzalez Baron, Manuel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (04) : 356 - 361